Takeda Pharmaceutical
TAK
12,40 €
Prix de l'action
0.07%
Changement (1 jour)
-2.14%
Changement (1 an)
Catégories
Takeda Pharmaceutical (TAK) - Dette totale
Dette totale au bilan au Mars 2025 : 26.07 Milliards d'euros
Selon les derniers rapports financiers de Takeda Pharmaceutical, la dette totale de l'entreprise est de 26.07 Milliards d'euros. La dette totale d'une entreprise est la somme de toutes les dettes courantes et non courantes.
Takeda Pharmaceutical - Dette totale au bilan (de 2008 à 2025)
Dette totale par année
| Année | Dette totale | Changement |
|---|---|---|
| 2024-03-31 | €29.64 Md | -2.02% |
| 2023-03-31 | €30.25 Md | -6.14% |
| 2022-03-31 | €32.23 Md | -9.67% |
| 2021-03-31 | €35.68 Md | -16.94% |
| 2020-03-31 | €42.96 Md | -6.93% |
| 2019-03-31 | €46.16 Md | 513.13% |
| 2018-03-31 | €7.52 Md | -21.74% |
| 2017-03-31 | €9.62 Md | 60.29% |
| 2016-03-31 | €6.00 Md | 6.05% |
| 2015-03-31 | €5.65 Md | -6.44% |
| 2014-03-31 | €6.04 Md | 24.93% |
| 2013-03-31 | €4.84 Md | -1.31% |
| 2012-03-31 | €4.90 Md | 2722.54% |
| 2011-03-31 | €0.17 Md | 17.84% |
| 2010-03-31 | €0.14 Md | -2.51% |
| 2009-03-31 | €0.15 Md | 627.39% |
| 2008-03-31 | €20.79 M | -71.88% |
| 2007-03-31 | €73.95 M | -17.06% |
| 2006-03-31 | €89.16 M | -33.02% |
| 2005-03-31 | €0.13 Md | 16.66% |
| 2004-03-31 | €0.11 Md | 15.91% |
| 2003-03-31 | €98.45 M | -26.73% |
| 2002-03-31 | €0.13 Md | -7.41% |
| 2001-03-31 | €0.14 Md |
Dette totale pour des entreprises similaires ou concurrentes
| Entreprise | Dette totale/th> | Dette totale différencediff. | Pays |
|---|---|---|---|
 Johnson & Johnson JNJ | €45.22 Md | 73.48% | 🇺🇸 USA |
 Sanofi SNY | €19.71 Md | -24.40% | 🇫🇷 France |
 Pfizer PFE | €53.05 Md | 103.49% | 🇺🇸 USA |
 Novartis NVS | €27.06 Md | 3.82% | 🇨🇭 Switzerland |
 Seagen
SGEN | €98.23 M | -99.62% | 🇺🇸 USA |
 Dr. Reddy's Laboratories RDY | €0.47 Md | -98.18% | 🇮🇳 India |
 Amgen AMGN | €49.66 Md | 90.51% | 🇺🇸 USA |
 GlaxoSmithKline GSK | €20.61 Md | -20.93% | 🇬🇧 UK |
 Merck MRK | €30.16 Md | 15.69% | 🇺🇸 USA |